In her current role, Dr. Ramani Wonderling serves as the scientific liaison between Abbott and its core laboratory customers, addressing technical questions and providing scientific proof sources.
Prior to this role, she has worked on the development of tests for hepatitis viruses, HIV, Chagas disease (parasitic disease that if left untreated can cause swelling/fever, or even congestive heart failure) and toxoplasmosis (common parasitic disease that can cause serious complications for pregnant women and people with weakened immune systems).
She has 17 patents, has given more than 800 scientific presentations and has several publications in peer-reviewed journals.
Prior to Abbott, she worked on cytokine (small protein) discovery, therapeutics and DNA vaccines at Heska Corporation.
Dr. Ramani Wonderling received her Ph.D. in microbiology and immunology from the University of South Carolina. She completed a postdoctoral fellowship at the National Institutes of Health (NIH) in Bethesda, Maryland and worked on adeno-associated virus (AAV) as a gene therapy vector.
